Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Por Ramjiawan, Rakesh R., Griffioen, Arjan W., Duda, Dan G.
Publicado no Angiogenesis (2017)

An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis

Por Reiberger, Thomas, Chen, Yunching, Ramjiawan, Rakesh R, Hato, Tai, Fan, Christopher, Samuel, Rekha, Roberge, Sylvie, Huang, Peigen, Lauwers, Gregory Y, Zhu, Andrew X, Bardeesy, Nabeel, Jain, Rakesh K, Duda, Dan G
Publicado no Nat Protoc (2015)

CXCR4 inhibition in tumor microenvironment facilitates anti-PD-1 immunotherapy in sorafenib-treated HCC in mice

Por Chen, Yunching, Ramjiawan, Rakesh R., Reiberger, Thomas, Ng, Mei R., Hato, Tai, Huang, Yuhui, Ochiai, Hiroki, Kitahara, Shuji, Unan, Elizabeth C., Reddy, Tejaswini P., Fan, Christopher, Huang, Peigen, Bardeesy, Nabeel, Zhu, Andrew X., Jain, Rakesh K., Duda, Dan G.
Publicado no Hepatology (2015)

Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors

Por Chen, Yunching, Liu, Ya-Chi, Sung, Yun-Chieh, Ramjiawan, Rakesh R., Lin, Ts-Ting, Chang, Chih-Chun, Jeng, Kuo-Shyang, Chang, Chiung-Fang, Liu, Chun-Hung, Gao, Dong-Yu, Hsu, Fu-Fei, Duyverman, Annique M., Kitahara, Shuji, Huang, Peigen, Dima, Simona, Popescu, Irinel, Flaherty, Keith T., Zhu, Andrew X., Bardeesy, Nabeel, Jain, Rakesh K., Benes, Cyril H., Duda, Dan G.
Publicado no Sci Rep (2017)